CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-03 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +58,648 | 58,648 | ||
| 2025-10-01 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +286,734 | 286,734 | ||
| 2024-10-03 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +12,082 | 12,082 | ||
| 2024-10-01 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +56,636 | 56,636 | ||
| 2024-10-01 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +29,493 | 29,493 | ||
| 2024-03-07 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 | ||
| 2023-10-04 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +210,225 | 210,225 | ||
| 2023-03-29 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +41,065 | 41,065 | ||
| 2022-10-05 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +42,239 | 42,239 | ||
| 2022-03-23 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +21,878 | 21,878 | ||
| 2021-10-05 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +25,245 | 25,245 | ||
| 2021-03-24 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +20,873 | 20,873 | ||
| 2020-10-05 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +85,586 | $0.51 | $44K | 85,586 |
| 2020-07-17 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2020-07-01 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +19,874 | $0.99 | $20K | 19,874 |
| 2020-04-20 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 1 of 1 · 16 trades